Literature DB >> 11509635

A role for IL-18 in neutrophil activation.

B P Leung1, S Culshaw, J A Gracie, D Hunter, C A Canetti, C Campbell, F Cunha, F Y Liew, I B McInnes.   

Abstract

IL-18 expression and functional activity has been identified in several autoimmune and infectious diseases. To clarify the potential role of IL-18 during early innate immune responses, we have explored the capacity of IL-18 to activate neutrophils. Human peripheral blood-derived neutrophils constitutively expressed IL-18R (alpha and beta) commensurate with the capacity to rapidly respond to IL-18. IL-18 induced cytokine and chemokine release from neutrophils that was protein synthesis dependent, up-regulated CD11b expression, induced granule release, and enhanced the respiratory burst following exposure to fMLP, but had no effect upon the rate of neutrophil apoptosis. The capacity to release cytokine and chemokine was significantly enhanced in neutrophils derived from rheumatoid arthritis synovial fluid, indicating differential responsiveness to IL-18 dependent upon prior neutrophil activation in vivo. Finally, IL-18 administration promoted neutrophil accumulation in vivo, whereas IL-18 neutralization suppressed the severity of footpad inflammation following carrageenan injection. The latter was accompanied by reduction in tissue myeloperoxidase expression and suppressed local TNF-alpha production. Together, these data define a novel role for IL-18 in activating neutrophils and thereby promoting early innate immune responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509635     DOI: 10.4049/jimmunol.167.5.2879

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  90 in total

1.  Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease.

Authors:  Pete Kaiser; Greg Underwood; Fred Davison
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  Role of interleukin 18 in rheumatoid arthritis.

Authors:  F Y Liew; X-Q Wei; I B McInnes
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 3.  Interleukin-18 as a potential target in inflammatory arthritis.

Authors:  J A Gracie
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 4.  Development of adjunctive therapies for bacterial meningitis and lessons from knockout mice.

Authors:  Robert Paul; Uwe Koedel; Hans-Walter Pfister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

5.  Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates.

Authors:  Vitaliano Cusumano; Angelina Midiri; Valentina Valeria Cusumano; Antonella Bellantoni; Giuseppe De Sossi; Giuseppe Teti; Concetta Beninati; Giuseppe Mancuso
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 6.  Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.

Authors:  Laura C O'Brien; Eleonora Mezzaroma; Benjamin W Van Tassell; Carlo Marchetti; Salvatore Carbone; Antonio Abbate; Stefano Toldo
Journal:  Mol Med       Date:  2014-06-12       Impact factor: 6.354

7.  Interleukin-18 primes the oxidative burst of neutrophils in response to formyl-peptides: role of cytochrome b558 translocation and N-formyl peptide receptor endocytosis.

Authors:  Carole Elbim; Cécile Guichard; Pham M C Dang; Michèle Fay; Eric Pedruzzi; Hélène Demur; Cécile Pouzet; Jamel El Benna; Marie-Anne Gougerot-Pocidalo
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

8.  Trauma-associated human neutrophil alterations revealed by comparative proteomics profiling.

Authors:  Jian-Ying Zhou; Ravi K Krovvidi; Yuqian Gao; Hong Gao; Brianne O Petritis; Asit K De; Carol L Miller-Graziano; Paul E Bankey; Vladislav A Petyuk; Carrie D Nicora; Therese R Clauss; Ronald J Moore; Tujin Shi; Joseph N Brown; Amit Kaushal; Wenzhong Xiao; Ronald W Davis; Ronald V Maier; Ronald G Tompkins; Wei-Jun Qian; David G Camp; Richard D Smith
Journal:  Proteomics Clin Appl       Date:  2013-05-22       Impact factor: 3.494

9.  Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction.

Authors:  Leo A B Joosten; Ruben L Smeets; Marije I Koenders; Liduine A M van den Bersselaar; Monique M A Helsen; Birgitte Oppers-Walgreen; Erik Lubberts; Yoichiro Iwakura; Fons A J van de Loo; Wim B van den Berg
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

10.  Tumor necrosis factor-alpha causes release of cytosolic interleukin-18 from human neutrophils.

Authors:  Christopher C Silliman; Marguerite R Kelher; Fabia Gamboni-Robertson; Christine Hamiel; Kelly M England; Charles A Dinarello; Travis H Wyman; Samina Y Khan; Nathan J D McLaughlin; Rachel S Bercovitz; Anirban Banerjee
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-11       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.